Lineage Cell Therapeutics, Inc.
LCTX
$0.4817
-$0.0183-3.66%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 34.69% | -20.86% | -16.18% | -6.82% | -38.67% |
| Total Receivables | -14.36% | -6.25% | -46.95% | -62.07% | 150.84% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 15.88% | -24.17% | -21.86% | -23.50% | 20.57% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 32.66% | -20.88% | -16.71% | -7.93% | -35.93% |
|
|
|||||
| Total Current Assets | 32.66% | -20.88% | -16.71% | -7.93% | -35.93% |
| Net Property, Plant & Equipment | -7.80% | -9.87% | -13.33% | -11.19% | -15.97% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -0.05% | -0.12% | -0.19% | -0.26% | -0.28% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.41% | 9.78% | 1.70% | -6.14% | -7.97% |
| Total Assets | 12.08% | -9.00% | -7.96% | -4.17% | -18.31% |
|
|
|||||
| Total Accounts Payable | -42.73% | -34.20% | 9.19% | -26.32% | -14.33% |
| Total Accrued Expenses | 1.02% | 10.69% | 5.28% | 56.82% | -32.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 30.61% | 21.47% | 12.97% | 14.33% | -7.35% |
| Total Finance Division Other Current Liabilities | -31.64% | -16.79% | -11.93% | -8.52% | 14.72% |
| Total Other Current Liabilities | -31.64% | -16.79% | -11.93% | -8.52% | 14.72% |
| Total Current Liabilities | -22.18% | -12.70% | -4.84% | -1.94% | -5.38% |
|
|
|||||
| Total Current Liabilities | -22.18% | -12.70% | -4.84% | -1.94% | -5.38% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -34.20% | -24.77% | -24.04% | -19.51% | -29.69% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.02% | -23.97% | -14.32% | -24.04% | -36.36% |
| Total Liabilities | -7.15% | -19.48% | -11.14% | -15.16% | -24.61% |
|
|
|||||
| Common Stock & APIC | 7.40% | 4.22% | 4.39% | 5.73% | 2.51% |
| Retained Earnings | -4.84% | -5.29% | -6.48% | -6.43% | -5.91% |
| Treasury Stock & Other | 6.26% | -38.68% | 5.40% | 10.81% | 14.09% |
| Total Common Equity | 23.59% | -2.83% | -6.01% | 2.77% | -13.53% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 23.59% | -2.83% | -6.01% | 2.77% | -13.53% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 1.93% | 4.46% | -1.14% | 1.60% | 0.50% |
| Total Equity | 24.17% | -2.80% | -6.15% | 2.86% | -13.78% |
|
|
|||||
